Guanmin Jiang

1.5k total citations · 2 hit papers
19 papers, 1.2k citations indexed

About

Guanmin Jiang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guanmin Jiang has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Guanmin Jiang's work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Immune cells in cancer (3 papers). Guanmin Jiang is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Immune cells in cancer (3 papers). Guanmin Jiang collaborates with scholars based in China, United States and Hong Kong. Guanmin Jiang's co-authors include Hongsheng Wang, Shaohui Cai, Jun Du, Xianzhang Bu, Rui Fang, Ge Zhang, Hao Wang, Fan Zhang, Hao Liu and Xianfeng Wang and has published in prestigious journals such as Journal of Hazardous Materials, Cancer Letters and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Guanmin Jiang

19 papers receiving 1.2k citations

Hit Papers

TGF-β induces M2-like macrophage polarization via SNAIL-m... 2016 2026 2019 2022 2016 2024 100 200 300 400

Peers

Guanmin Jiang
Sanchita Rauth United States
Xueping Fang United States
Pravin Kesarwani United States
Chaehwa Park South Korea
Guanmin Jiang
Citations per year, relative to Guanmin Jiang Guanmin Jiang (= 1×) peers Zheng Gong

Countries citing papers authored by Guanmin Jiang

Since Specialization
Citations

This map shows the geographic impact of Guanmin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanmin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanmin Jiang more than expected).

Fields of papers citing papers by Guanmin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanmin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanmin Jiang. The network helps show where Guanmin Jiang may publish in the future.

Co-authorship network of co-authors of Guanmin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guanmin Jiang. A scholar is included among the top collaborators of Guanmin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanmin Jiang. Guanmin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jiang, Guanmin, et al.. (2024). Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment. Journal of Materials Chemistry B. 12(27). 6532–6549. 43 indexed citations breakdown →
2.
Zheng, Wei, Tianchuan Zhu, Lantian Tang, et al.. (2023). Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer. Journal of Translational Medicine. 21(1). 383–383. 69 indexed citations
3.
He, Yuwen, Danyang Chen, Yanmei Yi, et al.. (2020). Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149. Molecular Therapy — Oncolytics. 17. 448–459. 24 indexed citations
4.
Li, Yuejin, Weiwei Wang, Yuan Jiang, et al.. (2018). Dinitrosopiperazine‐decreased PKP3 through upregulating miR‐149 participates in nasopharyngeal carcinoma metastasis. Molecular Carcinogenesis. 57(12). 1763–1779. 17 indexed citations
5.
Xu, Wei, Hao Liu, Zhigang Liu, et al.. (2018). Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells. Cancer Letters. 420. 1–13. 40 indexed citations
6.
Deng, Qianqian, Guanmin Jiang, Yingmin Wu, et al.. (2018). GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells. Journal of Hazardous Materials. 355. 1–9. 55 indexed citations
7.
Liu, Huifang, Zhigang Liu, Ping Xiao, et al.. (2017). Curcumin downregulates the expression of Snail via suppressing Smad2 pathway to inhibit TGF-β1-induced epithelial-mesenchymal transitions in hepatoma cells. Oncotarget. 8(65). 108498–108508. 26 indexed citations
8.
Wang, Zhaotong, Zhuojia Chen, Guanmin Jiang, et al.. (2016). Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells. Cellular Signalling. 28(5). 506–515. 73 indexed citations
10.
Liu, Zhi-Gang, Guanmin Jiang, Jiao Tang, et al.. (2016). c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma. Oncotarget. 7(40). 65946–65956. 43 indexed citations
11.
Jiang, Guanmin, Wei Xu, Jun Du, et al.. (2016). The application of the fibroblast activation protein α-targeted immunotherapy strategy. Oncotarget. 7(22). 33472–33482. 57 indexed citations
12.
Zhang, Fan, Hongsheng Wang, Xianfeng Wang, et al.. (2016). TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 7(32). 52294–52306. 405 indexed citations breakdown →
13.
Liu, Hao, Jiang Yin, Hongsheng Wang, et al.. (2015). FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells. Cellular Signalling. 27(3). 510–518. 130 indexed citations
14.
Jiang, Guanmin, Hongsheng Wang, Jun Du, et al.. (2015). Curcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma. Oncotarget. 6(28). 25932–25942. 41 indexed citations
15.
Zhang, Fan, Hao Liu, Guanmin Jiang, et al.. (2014). Changes in the proteomic profile during the differential polarization status of the human monocyte‐derived macrophage THP‐1 cell line. PROTEOMICS. 15(4). 773–786. 22 indexed citations
16.
Jiang, Guanmin, Hongsheng Wang, Fan Zhang, et al.. (2012). Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(3). 663–671. 82 indexed citations
17.
Jiang, Xiaoxin, Jufang Huang, Yan Jiang, et al.. (2012). Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients. BMC Immunology. 13(1). 62–62. 10 indexed citations
18.
Zhang, Peng, Guanmin Jiang, Jian Gao, et al.. (2012). SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells. Oncology Reports. 29(1). 269–275. 9 indexed citations
19.
Jiang, Guanmin, Yuwen He, Rui Fang, et al.. (2010). Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels. The International Journal of Biochemistry & Cell Biology. 42(11). 1840–1846. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026